Victory Financial Group’s AbbVie ABBV Stock Holding History

Victory Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.87M	Buy	8,582 +876	+11%	+$194K	0.23%	72
2025 Q4	$1.76M	Buy	7,706 +2,141	+38%	+$488K	0.22%	72
2025 Q3	$1.29M	Buy	5,565 +198	+4%	+$40.3K	0.18%	74
2025 Q2	$996K	Buy	5,367 +1,915	+55%	+$356K	0.16%	72
2025 Q1	$755K	Buy	3,452 +1,828	+113%	+$355K	0.15%	78
2024 Q4	$289K	Buy	+1,624	New	+$299K	0.08%	110

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Victory Financial Group's ABBV Position: Q1 2026 in Review

Victory Financial Group increased its AbbVie (ABBV) stake by 11% in Q1 2026, buying an estimated $194K and bringing the position to 8,582 shares worth $1.87M. The position accounts for 0.23% of the portfolio, ranked #72.

Victory Financial Group first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Victory Financial Group held 8,582 shares of AbbVie worth $1.87M as of Q1 2026.
Victory Financial Group bought 876 AbbVie shares in Q1 2026, an estimated $194K.
AbbVie made up 0.23% of Victory Financial Group's portfolio in Q1 2026, its #72 holding.
Victory Financial Group first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Victory Financial Group's 13F filing for Q1 2026, filed 27 Apr 2026.